The Parkinson’s disease drug market is currently characterized by a significant surge in demand, primarily fueled by the demographic shift toward an aging population. As the second most common neurodegenerative disorder, Parkinson’s disease requires lifelong management, which sustains a massive and consistent revenue stream for pharmaceutical manufacturers. The market is currently...